Search
Muvadenant
go.drugbank.com/drugs/DB21684ExperimentalMuvadenant is a small molecule drug. The usage of the INN stem '-adenant' in the name indicates that Muvadenant is a adenosin receptor antagonist.
Darbinurad
go.drugbank.com/drugs/DB21695ExperimentalDarbinurad is a small molecule drug. The usage of the INN stem '-inurad' in the name indicates that Darbinurad is a urate transporter inhibitor.
Remlifanserin
go.drugbank.com/drugs/DB21707ExperimentalRemlifanserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Remlifanserin is a serotonin receptor antagonist.
Envudeucitinib
go.drugbank.com/drugs/DB21716InvestigationalEnvudeucitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Envudeucitinib is a Janus kinase inhibitor.
Zemprocitinib
go.drugbank.com/drugs/DB21719ExperimentalZemprocitinib is a small molecule drug. The usage of the INN stem '-citinib' in the name indicates that Zemprocitinib is a Janus kinase inhibitor.
UB-612
go.drugbank.com/drugs/DB16444InvestigationalIt was able to reduce viral load and prevent COVID-19 infection in a mouse challenge model and in rhesus macaques[L30653, L30658]. … In rats, toxicity studies have so far shown favourable safety for this vaccine[L30653, L30658], Phase 1 trial is currently ongoing in Taiwan (NCT04545749).
Bombesin
go.drugbank.com/drugs/DB11724Investigational-7548 in Patients With Prostate Cancer and Healthy Volunteers). … Bombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86
BGT-DTDS
go.drugbank.com/drugs/DB18664ExperimentalIt is under investigation for the treatment of dopamine transporter deficiency syndrome (DTDS). … BGT-DTDS is an investigational gene therapy comprising an adeno-associated viral vector type 2 (AAV2) encoding the human _SLC6A3_ gene.
AZD-8186
go.drugbank.com/drugs/DB15029InvestigationalAZD-8186 is under investigation in clinical trial NCT03218826 (PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot
ABT-072
go.drugbank.com/drugs/DB15156InvestigationalABT-072 is under investigation in clinical trial NCT00890318 (A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat